Hepatic Angiosarcoma with Peliosis Hepatis.

dietary supplements disseminated intravascular coagulation laparoscopy liver biopsy positron emission tomography

Journal

Internal medicine (Tokyo, Japan)
ISSN: 1349-7235
Titre abrégé: Intern Med
Pays: Japan
ID NLM: 9204241

Informations de publication

Date de publication:
15 Apr 2023
Historique:
medline: 18 4 2023
pubmed: 8 9 2022
entrez: 7 9 2022
Statut: ppublish

Résumé

A 59-year-old woman presented to our hospital with liver dysfunction. Imaging revealed multiple lesions in the liver. The patient was diagnosed with peliosis hepatis using percutaneous and laparoscopic biopsies. However, her condition worsened with the appearance of new, obvious mass-forming lesions. Therefore, she underwent a second percutaneous biopsy of these lesions and was diagnosed with hepatic angiosarcoma. Her condition progressed rapidly, and she died two weeks after the diagnosis. Diagnosis of hepatic angiosarcoma in the early stages is difficult. It should be noted that hepatic angiosarcoma may be associated with the development of peliosis hepatis.

Identifiants

pubmed: 36070948
doi: 10.2169/internalmedicine.0315-22
pmc: PMC10183276
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1157-1166

Références

World J Surg Oncol. 2008 Sep 30;6:104
pubmed: 18826593
Rev Esp Enferm Dig. 2009 Jun;101(6):430-4, 434-7
pubmed: 19630468
Br J Radiol. 2017 Jul;90(1075):20170039
pubmed: 28471264
Forensic Sci Int. 2005 Apr 20;149(1):25-33
pubmed: 15734106
J Med Case Rep. 2015 Sep 12;9:194
pubmed: 26362063
BMC Gastroenterol. 2021 Apr 7;21(1):156
pubmed: 33827427
World J Gastroenterol. 2007 Sep 14;13(34):4646-8
pubmed: 17729423
Infection. 2014 Feb;42(1):185-9
pubmed: 23765512
Eur J Surg Oncol. 2015 Sep;41(9):1137-43
pubmed: 26008857
Am J Pathol. 1978 Aug;92(2):349-76
pubmed: 567014
Oncol Lett. 2017 Apr;13(4):2765-2769
pubmed: 28454464
Semin Ultrasound CT MR. 2011 Oct;32(5):405-21
pubmed: 21963162
Int J Clin Exp Pathol. 2017 Nov 01;10(11):11211-11218
pubmed: 31966472
Hepatol Res. 2014 Oct;44(10):E297-303
pubmed: 24147907
SAGE Open Med Case Rep. 2021 Sep 17;9:2050313X211046726
pubmed: 34552751
Int J Surg Case Rep. 2021 Jul;84:106090
pubmed: 34139418
J Comput Assist Tomogr. 1989 Sep-Oct;13(5):910-2
pubmed: 2778153
Ann Intern Med. 1974 Nov;81(5):610-8
pubmed: 4423214
J Hepatobiliary Pancreat Surg. 2004;11(5):371-4
pubmed: 15549441
BMJ Case Rep. 2013 Sep 26;2013:
pubmed: 24072833
J Gastrointest Cancer. 2021 Jun;52(2):771-775
pubmed: 32894473
Oncologist. 2009 Nov;14(11):1088-94
pubmed: 19889716
Front Oncol. 2022 Mar 03;12:809068
pubmed: 35311098
J Hepatobiliary Pancreat Surg. 2009;16(4):566-70
pubmed: 19183829
World J Gastrointest Oncol. 2022 May 15;14(5):1050-1056
pubmed: 35646288
Medicine (Baltimore). 2017 Mar;96(13):e6471
pubmed: 28353584
Radiology. 2002 Mar;222(3):667-73
pubmed: 11867783
Medicine (Baltimore). 2018 Nov;97(47):e13321
pubmed: 30461646
Jpn J Clin Oncol. 2006 Jul;36(7):403-9
pubmed: 16782729
Arch Pathol Lab Med. 2004 Nov;128(11):1283-5
pubmed: 15504065
Ann Oncol. 2009 Apr;20(4):780-7
pubmed: 19179547
BMJ Case Rep. 2018 Aug 9;2018:
pubmed: 30093472
Cancer Res Treat. 2021 Oct;53(4):1195-1203
pubmed: 33540493
Cardiovasc Intervent Radiol. 1996 Sep-Oct;19(5):360-3
pubmed: 8781161
Hiroshima J Med Sci. 2011 Dec;60(4):91-6
pubmed: 22389954
J Ultrasound Med. 1996 Mar;15(3):257-60
pubmed: 8919510
World J Gastroenterol. 2015 Dec 14;21(46):13188-94
pubmed: 26675327
Intern Med. 2012;51(20):2899-904
pubmed: 23064564
Lancet Oncol. 2010 Oct;11(10):983-91
pubmed: 20537949
World J Gastrointest Oncol. 2020 Mar 15;12(3):248-266
pubmed: 32206176
World J Gastroenterol. 2015 May 21;21(19):6088-96
pubmed: 26019478
J Dig Dis. 2012 Jul;13(7):381-5
pubmed: 22713088

Auteurs

Kensuke Kitsugi (K)

Department of Internal Medicine II, Hamamatsu University School of Medicine, Japan.

Kazuhito Kawata (K)

Department of Internal Medicine II, Hamamatsu University School of Medicine, Japan.

Moe Matsumoto (M)

Department of Internal Medicine II, Hamamatsu University School of Medicine, Japan.

Masahiro Umemura (M)

Department of Internal Medicine II, Hamamatsu University School of Medicine, Japan.

Tomohiko Hanaoka (T)

Department of Internal Medicine II, Hamamatsu University School of Medicine, Japan.

Maho Yamashita (M)

Department of Internal Medicine II, Hamamatsu University School of Medicine, Japan.

Shingo Takatori (S)

Department of Internal Medicine II, Hamamatsu University School of Medicine, Japan.

Jun Ito (J)

Department of Internal Medicine II, Hamamatsu University School of Medicine, Japan.

Kazuyoshi Ohta (K)

Department of Internal Medicine II, Hamamatsu University School of Medicine, Japan.

Takeshi Chida (T)

Department of Internal Medicine II, Hamamatsu University School of Medicine, Japan.

Hidenao Noritake (H)

Department of Internal Medicine II, Hamamatsu University School of Medicine, Japan.

Takafumi Suda (T)

Department of Internal Medicine II, Hamamatsu University School of Medicine, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH